Kolexia
Aussedat Guillaume Oncologie hémato.
Aussedat Guillaume
Oncologie hémato.
Centre Hospitalier Bretagne Atlantique
Vannes, France
30 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Lymphome B Lymphome B diffus à grandes cellules Lymphome malin non hodgkinien Maladie de Hodgkin Myélome multiple Tumeurs de la surrénale Lymphome composite Insuffisance surrénale

Collaborateurs

Voir plus
Ghesquieres Herve
Ghesquieres Herve
Hôpital Lyon Sud, Pierre-Bénite, France
Safar Violaine
Safar Violaine
Hôpital Lyon Sud, Pierre-Bénite, France
Salles Gilles
Salles Gilles
Hôpital Lyon Sud, Pierre-Bénite, France
Lequeu Hélène
Lequeu Hélène
Hôpital Lyon Sud, Pierre-Bénite, France

Industries

Voir plus
B3TSI
8 collaboration(s)
Dernière en 2022
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Skeletal Muscle Index, As a Measure of Muscle Mass, Is a Significant Prognostic Factor for Newly Diagnosed Diffuse Large B-Cell Primary CNS Lymphoma Patients
65th ASH Annual Meeting Abstracts   02 novembre 2023
HLA-DR expression on monocytes and outcome of anti-CD19 CAR T-cell therapy for large B-cell lymphoma.
Blood advances   06 mars 2023
Evaluation of Participation and Recruitment Bias in a Prospective Real-Life Multicentric Cohort « Real World Data in Lymphoma and Survival in Adults » (REALYSA study) for Newly Diagnosed Lymphoma Patients over One Year in a Hematology Department of Teaching Hospital
Annual Meeting Abstracts 2022   15 novembre 2022
Outcome in Multiple Myeloma Patients Treated in the Era of Modern Therapies Who Were Admitted to Intensive Care: A Retrospective Analysis from a Teaching Hospital between 2014 and 2019
Annual Meeting Abstracts 2022   15 novembre 2022
Lymphoma diagnosis: lessons learned from the comparison of histology and cytology associated with flow cytometry.
Annales de biologie clinique   30 juin 2022
Rituximab in combination with adapted-dose of ifosfamide and etoposide as salvage treatment in elderly refractory/relapsed diffuse large B-cell lymphoma patients non-candidate for high dose therapy: a retrospective study.
Leukemia & lymphoma   31 octobre 2021
PVAG Regimen (Prednisone, Vinblastine, Doxorubicin, Gemcitabine) Used in Real-Life Setting in First Line Therapy for Elderly Classical Hodgkin Lymphoma Patients: A Retrospective Study of Lysa Centers
Blood   05 novembre 2020
Composite and sequential lymphoma between classical Hodgkin lymphoma and primary mediastinal lymphoma/diffuse large B-cell lymphoma, a clinico-pathological series of 25 cases.
British journal of haematology   06 février 2020
One translocation for 2 lymphoid neoplasms.
Blood   20 août 2019
Ritumixab in Combination with Adapted-Dose of Ifosfamide and Etoposide As Salvage Treatment in Elderly Refractory/Relapsed Diffuse Large B-Cell Lymphoma Patients Non-Candidate for High Dose Therapy: A Retrospective Study of Lyon Hospital University
Blood   29 novembre 2018